Heron Therapeutics | HRTX - Stock





Stock Veränderung Datum
ALKERMES USD 336.7M 140.08M 2026-03
Alnylam Pharmaceuticals USD 200.15M 117.43M 2026-03
Amarin USD 183.58M 12.32M 2026-03
ANI Pharmaceuticals USD 143.47M 401K 2026-03
Anika Therapeutics USD 22.84M 4.05M 2026-03
Arrowhead Research USD -173.08M 173.08M 2024-12
Eisai JPY 236.46B 9.14B 2025-09
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Esperion Therapeutics USD 104.21M 915K 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Insmed USD 132.91M 841K 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
Merck USD 6.48B 179M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Omeros USD 712K 266K 2021-09
Pacira USD 150.37M 2.49M 2026-03
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Roche Holding CHF 7.6B 9M 2025-06
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
Veracyte USD 21.42M 870K 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03